|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for ATIC |
Basic gene info. | Gene symbol | ATIC |
Gene name | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | |
Synonyms | AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH | |
Cytomap | UCSC genome browser: 2q35 | |
Genomic location | chr2 :216176678-216214496 | |
Type of gene | protein-coding | |
RefGenes | NM_004044.6, | |
Ensembl id | ENSG00000138363 | |
Description | 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleotide transformylase/inosinicaseAICAR formyltransferase/IMP cyclohydrolase bifunctional enzymeAICARFT/IMPCHASEbifunctional purine biosynthesis protein PURHepididymis secretory sperm binding protein Li 7 | |
Modification date | 20141207 | |
dbXrefs | MIM : 601731 | |
HGNC : HGNC | ||
Ensembl : ENSG00000138363 | ||
HPRD : 03434 | ||
Vega : OTTHUMG00000133023 | ||
Protein | UniProt: P31939 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ATIC | |
BioGPS: 471 | ||
Gene Expression Atlas: ENSG00000138363 | ||
The Human Protein Atlas: ENSG00000138363 | ||
Pathway | NCI Pathway Interaction Database: ATIC | |
KEGG: ATIC | ||
REACTOME: ATIC | ||
ConsensusPathDB | ||
Pathway Commons: ATIC | ||
Metabolism | MetaCyc: ATIC | |
HUMANCyc: ATIC | ||
Regulation | Ensembl's Regulation: ENSG00000138363 | |
miRBase: chr2 :216,176,678-216,214,496 | ||
TargetScan: NM_004044 | ||
cisRED: ENSG00000138363 | ||
Context | iHOP: ATIC | |
cancer metabolism search in PubMed: ATIC | ||
UCL Cancer Institute: ATIC | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of ATIC in cancer cell metabolism | 1. Duval N, Luhrs K, Wilkinson TG, 2nd, Baresova V, Skopova V, et al. (2013) Genetic and metabolomic analysis of AdeD and AdeI mutants of de novo purine biosynthesis: cellular models of de novo purine biosynthesis deficiency disorders. Mol Genet Metab 108: 178-189. doi: 10.1016/j.ymgme.2013.01.002. pmid: 4296673. go to article |
Top |
Phenotypic Information for ATIC(metabolism pathway, cancer, disease, phenome) |
![]() | |
Cancer | CGAP: ATIC |
Familial Cancer Database: ATIC |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
![]() | |
KEGG_PURINE_METABOLISM REACTOME_METABOLISM_OF_NUCLEOTIDES REACTOME_PURINE_METABOLISM |
![]() | |
OMIM | 601731; gene. 608688; phenotype. |
Orphanet | 250977; AICA-ribosiduria. |
Disease | KEGG Disease: ATIC |
MedGen: ATIC (Human Medical Genetics with Condition) | |
ClinVar: ATIC | |
Phenotype | MGI: ATIC (International Mouse Phenotyping Consortium) |
PhenomicDB: ATIC |
Mutations for ATIC |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
![]() |
- Statistics for Tissue and Mutation type | Top |
![]() |
- For Inter-chromosomal Variations |
There's no inter-chromosomal structural variation. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
![]() |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
ovary | ATIC | chr2 | 216187830 | 216187850 | ABCA12 | chr2 | 215916028 | 215916048 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
![]() |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows ATIC related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
DB224490 | ATIC | 1 | 286 | 2 | 216176804 | 216182957 | NAB1 | 285 | 537 | 2 | 191518452 | 191523904 | |
BC007306 | SNUPN | 1473 | 1497 | 15 | 75918632 | 75918656 | ATIC | 1489 | 3397 | 2 | 216176838 | 216214479 | |
BU675973 | ATIC | 18 | 118 | 2 | 216214387 | 216214487 | ATIC | 113 | 236 | 2 | 216214262 | 216214385 | |
BE144253 | EFNB2 | 26 | 84 | 13 | 107163028 | 107163086 | ATIC | 78 | 576 | 2 | 216212908 | 216213407 |
![]() |
Top |
![]() |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 2 |   |   |   |   |   |   |   |   |   | 1 |   |   |   |   |   |   | |||
GAIN (# sample) | 1 |   |   |   |   |   |   |   |   |   | 1 |   |   |   |   |   |   | |||
LOSS (# sample) | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
![]() |
|
![]() |
Top |
![]() |
Stat. for Non-Synonymous SNVs (# total SNVs=4) | (# total SNVs=2) |
![]() | ![]() |
(# total SNVs=0) | (# total SNVs=0) |
Top |
![]() |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr2:216189997-216189997 | p.K108K | 1 |
chr2:216190751-216190751 | p.R141* | 1 |
chr2:216198130-216198130 | p.D291V | 1 |
chr2:216200820-216200820 | p.K357K | 1 |
chr2:216203553-216203553 | p.L384F | 1 |
chr2:216214270-216214270 | p.A557A | 1 |
chr2:216177279-216177279 | p.A26A | 1 |
chr2:216177302-216177302 | p.S34F | 1 |
Top |
![]() |
|
![]() |
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 3 | 1 |   | 22 |   |   | 2 |   | 1 |   |   | 5 | 2 | 3 |   |   | 5 | 10 |   | 14 |
# mutation | 3 | 1 |   | 13 |   |   | 2 |   | 1 |   |   | 5 | 2 | 3 |   |   | 5 | 11 |   | 13 |
nonsynonymous SNV | 1 | 1 |   | 9 |   |   | 2 |   |   |   |   | 4 | 1 | 2 |   |   | 4 | 7 |   | 8 |
synonymous SNV | 2 |   |   | 4 |   |   |   |   | 1 |   |   | 1 | 1 | 1 |   |   | 1 | 4 |   | 5 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
![]() |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr2:216203555 | p.L384L | 6 |
chr2:216203554 | p.L384P | 5 |
chr2:216203539 | p.R379Q | 3 |
chr2:216191614 | p.V201I | 3 |
chr2:216211546 | p.A462V | 2 |
chr2:216189966 | p.S34F | 1 |
chr2:216197139 | p.T182R | 1 |
chr2:216214333 | p.L351L | 1 |
chr2:216177302 | p.A557A | 1 |
chr2:216200802 | p.S34S | 1 |
![]() |
![]() |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for ATIC |
![]() |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
![]() |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
Top |
![]() |
* This plots show the correlation between CNV and gene expression. |
![]() | |
![]() |
Top |
Gene-Gene Network Information |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() | |||||
AAMP,ATIC,C2orf47,COQ5,DNPEP,METTL21A,EEF2KMT, FARSB,GMPPA,GRPEL1,MRPL44,NDUFA10,NDUFB3,NIF3L1, ORMDL2,PSMD14,PSMD1,RPE,SMARCAL1,SUMO1,XRCC5 | ATIC,MISP,DBNDD1,ETNK2,FAM83A,GSS,HSPE1, MIPEP,MRPL13,PDCL3,PDF,PRR15L,SLC50A1,SEPHS2, SNRPD3,STARD10,NELFCD,TRUB2,TSPAN1,TSTA3,TTC39A | ||||
![]() | |||||
ATIC,BCS1L,CIAO1,CPSF3,HSPD1,METTL5,MFF, NIFK,MRPL30,MTIF2,NOL10,NOP58,OLA1,PNPT1, SLC5A6,SMYD5,SSB,WDR12,WDR75,XRCC5,ZC3H15 | ATAD2,ATIC,BUB1B,DTL,E2F1,EXOSC10,LMNB1, MCM2,MCM4,MCM7,MTHFD1,NAT10,NCAPD3,NUP155, PAICS,PRPF19,RRM1,SCFD2,SSRP1,TRAP1,WDHD1 |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
![]() |
Top |
Pharmacological Information for ATIC |
![]() |
DB Category | DB Name | DB's ID and Url link |
Chemistry | BindingDB | P31939; -. |
Chemistry | ChEMBL | CHEMBL2518; -. |
Organism-specific databases | PharmGKB | PA25094; -. |
Organism-specific databases | CTD | 471; -. |
![]() |
* Gene Centered Interaction Network. |
![]() |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00116 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved; nutraceutical | Tetrahydrofolic acid | ![]() | ![]() |
DB00642 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved; investigational | Pemetrexed | ![]() | ![]() |
DB01700 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | experimental | Aicar | ![]() | ![]() |
DB01972 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | experimental | Guanosine-5'-Monophosphate | ![]() | ![]() |
DB02309 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | experimental | 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine | ![]() | ![]() |
DB03442 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | experimental | 2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid | ![]() | ![]() |
DB04057 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | experimental | Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor | ![]() | ![]() |
DB00145 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved; nutraceutical | Glycine | ![]() | ![]() |
DB00130 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved; nutraceutical; investigational | L-Glutamine | ![]() | ![]() |
DB00158 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved; nutraceutical | Folic Acid | ![]() | ![]() |
DB00563 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved | Methotrexate | ![]() | ![]() |
DB00795 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved | Sulfasalazine | ![]() | ![]() |
DB00640 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | approved; investigational | Adenosine | ![]() | ![]() |
Top |
Cross referenced IDs for ATIC |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |